STOCK TITAN

P3 HEALTH PARTNERS (PIII) Stock News

PIII Nasdaq

Welcome to our dedicated page for P3 HEALTH PARTNERS news (Ticker: PIII), a resource for investors and traders seeking the latest updates and insights on P3 HEALTH PARTNERS stock.

P3 Health Partners Inc. reports developments in population health management, value-based primary care and physician-led care coordination. The company supports community providers through administrative services, clinical operations, data-driven care enablement and partnerships tied to Medicare Advantage, accountable care organizations and delegated-risk arrangements.

Recurring updates include quarterly results, guidance, revenue trends, capitated revenue per member, medical margin, adjusted EBITDA and operating changes in the Care Enablement Model. Company news also covers payer and provider agreements, ACO management services, market expansion, investor conference participation and joint venture activity such as the P3 Commonwealth Innovation MSO.

Rhea-AI Summary

P3 Health Partners has completed its business combination with Foresight Acquisition Corp., with trading commencing on December 6, 2021, under the ticker symbols PIII and PIIIW on Nasdaq. The merger positions P3 as a public company aiming to improve population health management through its value-based care model, which focuses on empowering patients and providers. P3's management team, led by physician-experts, is committed to expanding operations and addressing significant healthcare challenges, including rising costs and access issues.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5575.11%
Tags

FAQ

What is the current stock price of P3 HEALTH PARTNERS (PIII)?

The current stock price of P3 HEALTH PARTNERS (PIII) is $10.07 as of July 21, 2026.

What is the market cap of P3 HEALTH PARTNERS (PIII)?

The market cap of P3 HEALTH PARTNERS (PIII) is approximately 35.3M.